IDEXX Laboratories, Inc. Share Price
Equities
IDXX
US45168D1046
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
540.9 USD | -1.38% | +11.06% | -2.54% |
14/05 | Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $596 From $620 | MT |
02/05 | BNP Paribas Adjusts Price Target on IDEXX Laboratories to $641 From $653 | MT |
Sales 2024 * | 394.41Cr 33TCr | Sales 2025 * | 434.27Cr 36TCr | Capitalization | 4.53TCr 3,78100Cr |
---|---|---|---|---|---|
Net income 2024 * | 92Cr 7.7TCr | Net income 2025 * | 103.7Cr 8.65TCr | EV / Sales 2024 * | 11.6 x |
Net Debt 2024 * | 40Cr 3.3TCr | Net Debt 2025 * | 22Cr 1.86TCr | EV / Sales 2025 * | 10.5 x |
P/E ratio 2024 * |
48.8
x | P/E ratio 2025 * |
43.2
x | Employees | 11,000 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.19% |
Latest transcript on IDEXX Laboratories, Inc.
1 day | -1.38% | ||
1 week | +11.06% | ||
Current month | +9.78% | ||
1 month | +10.11% | ||
3 months | -4.90% | ||
6 months | +17.45% | ||
Current year | -2.54% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 63 | 01/12/01 | |
Brian McKeon
DFI | Director of Finance/CFO | 61 | 01/03/01 |
John Hart
COO | Chief Operating Officer | - | 01/08/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel Junius
BRD | Director/Board Member | 71 | 11/14/11 |
M. Szostak
BRD | Director/Board Member | 73 | 16/12/16 |
Chairman | 61 | 19/16/19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
8.32% | 1 M€ | -.--% | ||
1.59% | 17 M€ | +7.35% | - | |
1.14% | 2 M€ | -1.17% | - |
Date | Price | Change | Volume |
---|---|---|---|
16/24/16 | 540.9 | -1.38% | 523,050 |
15/24/15 | 548.5 | +5.26% | 823,800 |
14/24/14 | 521.1 | +3.60% | 636,588 |
13/24/13 | 503 | -1.33% | 374,410 |
10/24/10 | 509.8 | +1.80% | 526,504 |
Delayed Quote Nasdaq, May 17, 2024 at 01:30 am IST
More quotesEPS Revisions
- Stock Market
- Equities
- IDXX Stock